We treated MCF-7 (p53-positive), MDA-MB-231(triple negative) breast cancer cells and HCT116 (p53-positive) colon cancer cells with commonly used chemotherapeutics: irinotecan (IRI), doxorubicin (DOXO) and methotrexate (MTX). Here, TP53 is linked to colonic neoplasm.